openPR Logo
Press release

Paclitaxel Injection Market driven by advantages of Paclitaxel injection such as immediate results, easy availability and better efficacy

11-24-2016 01:54 PM CET | Health & Medicine

Press release from: TMR - Research Reports

Paclitaxel Injection Market driven by advantages of Paclitaxel

Paclitaxel injection is a viscous anticancer drug, derived from the bark of the Pacific yew tree. Paclitaxel belongs to the group of drugs called antineoplastic. Paclitaxel injection is primarily used to treat various advanced stage cancer of the breast,ovaries, Kaposi sarcoma and non-small cell lung cancer. It is type of cytoskeletal medication that targets tubulin, which are a type of globular proteins. The body cells that have defects in chromosome segregation, mitotic spindle assembly and cell division are treated Paclitaxel. Paclitaxel works by inhibiting the growth of cancer cells and by stabilizing the microtubule polymer. Paclitaxel injection should be administered under the supervision of an oncologists with experience in chemotherapy. Paclitaxel injection is used against some of the majormedical conditions-

Bladder cancer
Esophageal cancer
Cervical cancer
Endometrial cancer
Throat cancer
Non-small cell lung cancer
Kaposi's sarcoma
Stomach cancer
Testicular cancer
Fallopian tube cancer

Advantages of Paclitaxel injection such as immediate results, easy availability and better efficacy are some of the factors that are expected to drive the global Paclitaxel injection market. However, adverse effects such as allergy, leucopenia, blood clots, fever, diarrhea and weight loss are few drawbacksthat could hinder the growth of global Paclitaxel injection market. Moreover, stringent regulatory procedure could also act as the hindrance for the global market.

Download exclusive Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2025

In the geographical perspective, North America is the largest market for Paclitaxel injection owing to the high incidence and prevalence rate of various cancers. The Asian-Pacific and European region arealso expected to be a potential markets for Paclitaxel injection owing to the increased number of cases of advanced stage cancer patients.

The companies involved in development and manufacturing of Paclitaxel injection are AbraxisBioScience Inc., Abbott Laboratories, Bristol-Myers Squibb, Fresenius Kabi Oncology Ltd., Onco Therapies Ltd., Strides Arcolab Ltd., Sagent Pharmaceuticals Inc. and Novasep, amongst others.

Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact us:
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Paclitaxel Injection Market driven by advantages of Paclitaxel injection such as immediate results, easy availability and better efficacy here

News-ID: 386463 • Views:

More Releases from TMR - Research Reports

Visualization and 3D Rendering Software Market: On-Premise Deployment Presently …
The global market for visualization and 3D rendering features a largely consolidated vendor landscape, with the leading three vendors accounting for a nearly 80% of the overall revenue generated in the market in 2016, observes Transparency Market Research in a recent report. These three vendors, namely Autodesk Inc., Dassault Systems, and NVIDIA Corporation, have strengthened their positions in the market with the help of cost competitive pricing, continuous introduction of
Digital Door Lock Systems Market: Enhanced Security Requirements to Propel the D …
According to a new market report published by Transparency Market Research titled “Digital Door Lock Systems Market–Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026,” the global digital door lock systems market was valued at US$ 1,059.5 Mn in 2017 and is expected to expand at a CAGR of 30.25% from 2018 to 2026, reaching US$ 14,877.6 Mn by the end of the forecast period. digital door lock systems market
Transportation Management System Market: Advance Technologies in All the Sectors …
A transportation management system (TMS) refers to a subset of supply chain management and is centered mostly on logistics and transportation. The augmented use of cloud computing technologies for managing supply chain activities is one of the significant and major trends that have been prevailing in the world market for transportation management systems. Cloud-based deployments, in general, need less configuration and customization. These two factors are triggering down the cost
Energy Recovery Ventilators Market: Rising Awareness of Importance of Indoor Air …
Characterized by the presence of a handful of dominant players, namely United Technologies Corp., LG Electronics, Daikin Industries Ltd., Fujitsu Ltd., and Munters Corp., the global energy recovery ventilators market features intense competition, reveals Transparency Market Research (TMR) in a new report. Going forward, the rising number of players seeking entry will further intensify competition in the market. Expansion of product portfolio which has been the focus of established companies to

All 5 Releases


More Releases for Paclitaxel

Major Force in the Paclitaxel Injection Market 2025: Rising Incidence Of Breast …
How Will the Paclitaxel Injection Market Grow, and What Is the Projected Market Size? The paclitaxel injection market has seen rapid growth in recent years. It will increase from $6.02 billion in 2024 to $6.87 billion in 2025, at a CAGR of 14.1%. This growth is driven by clinical research, the rising incidence of cancer, greater patient awareness and education, and the globalization of the pharmaceutical industry. The paclitaxel injection market is
Paclitaxel Injection Global Market Report 2024 - Paclitaxel Injection Market Sha …
"The Business Research Company recently released a comprehensive report on the Global Paclitaxel Injection Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry. According to The Business Research Company's, The paclitaxel injection
Global Albumin-bound Paclitaxel Market |Bound for Success: Navigating the Global …
Global Albumin-bound Paclitaxel Market Overview The Albumin-bound Paclitaxel market is a dynamic and multifaceted landscape that encompasses various products, services, and industries. It is characterized by intense competition, rapid innovation, changing consumer behavior, and evolving market trends. Businesses operating in the Albumin-bound Paclitaxel market need to have a deep understanding of the market dynamics, including its size, growth rate, customer preferences, competitive landscape, and regulatory environment. Market research reports providing a comprehensive
Paclitaxel HPLC Global Market Research Report 2025
Paclitaxel HPLC Report by Material, Application, and Geography � Global Forecast to 2022 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, united Kingdom, Japan, South Korea and China). Access more details about this report at: https://www.research2reports.com/report-chemical/paclitaxel-hplc-market/81094 The report firstly introduced the Paclitaxel HPLC basics: definitions, classifications, applications and market
Paclitaxel Global Market Research Report 2025
Paclitaxel Report by Material, Application, and Geography � Global Forecast to 2022 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, united Kingdom, Japan, South Korea and China). Access more details about this report at: https://www.research2reports.com/report-medical-devices/paclitaxel-market-3/81092 The report firstly introduced the Paclitaxel basics: definitions, classifications, applications and market overview; product
Global Paclitaxel Market Research Report 2017: Novasep, Samyang
In this report, the global Paclitaxel market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Paclitaxel in these regions, from 2012 to 2022 (forecast), covering North America Europe China Japan Southeast Asia India Fill